AIP
JNJ icon

Arrowpoint Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Arrowpoint Investment Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,600
Closed -$265K – 476
2025
Q1 		$265K Buy
1,600
+600
+60% +$93.9K 0.03% 618
2024
Q4 		$145K Buy
+1,000
New +$155K 0.03% 489

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Arrowpoint Investment Partners's JNJ Position: Q2 2026 in Review

Arrowpoint Investment Partners sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 7,902 shares — an estimated $1.93M sold.

Arrowpoint Investment Partners first reported a position in JNJ in Q4 2025 and held it in 2 quarters. The position peaked at $65M in Q4 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Arrowpoint Investment Partners reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 7,902 Johnson & Johnson shares in Q2 2026, an estimated $1.93M.
  • Arrowpoint Investment Partners first reported a position in Johnson & Johnson in Q4 2025 and held it in 2 quarters.
  • Arrowpoint Investment Partners's Johnson & Johnson position peaked at $65M in Q4 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.